EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia

Xiaolin Zhai, Saibing Qi, Xiyan Wang, Wei Zhang, Mengyun Chen, Qiujin Shen, Xiaowen Gong, Wangsong Zhai, Sichang Liu, Xuan Liang, Yueshen Ma, Zhen Song und 6 weitere

Research and Practice in Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.rpth.2026.106916 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026. Verfasst von Xiaolin Zhai und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Artificial Intelligence, Decision Support Techniques. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Newly diagnosed severe primary immune thrombocytopenia (ITP) with a platelet count of ≤10 × 109/L and clinically important bleeding requiring treatment is a medical emergency.

Objectives

Using early kinetics of complete blood counts (CBC) to predict time interval to confirmed response in newly diagnosed severe primary ITP in adults.

Methods

We used a training cohort of 85 adults with newly diagnosed severe primary ITP to develop an artificial intelligence model predicting confirmed response. The model used CBC values over the initial 5 days of therapy to classify subjects into 3 strata: high-confidence fast response, lower-confidence fast response, and slow/no response. We validated the model in an independent cohort of 59 subjects.

Results

Concordance between the model-computed risk stratification and time to confirmed response is 0.78 (95% CI, 0.73, 0.82) and 0.78 (95% CI, 0.72, 0.83) in the training and validation cohorts, respectively. SHapley Additive exPlanations analyses indicated that the most informative covariates are age and kinetics of platelet count, mean red blood cell (RBC) volume, immature platelet fraction, standard deviation of RBC distribution width, mean RBC hemoglobin concentration, and immature reticulocyte percentage during days 3-5 of therapy.

Conclusion

Our study should be treated as hypothesis-generating. Early dynamic patterns of CBC values might be used by artificial intelligence to predict the likelihood and speed of reaching confirmed response in adults with newly diagnosed severe primary ITP and might assist decision on timely therapy adjustment. Prospective testing and independent validation in non-Chinese cohorts and cohorts treated with different paradigms are needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicArtificial IntelligenceDecision Support TechniquesHumansFemaleMaleAdultPlatelet CountMiddle AgedSeverity of Illness IndexTreatment OutcomePredictive Value of TestsPrediction AlgorithmsAgedPredictive Learning ModelsReproducibility of ResultsTime FactorsYoung Adult

Stichwörter der Autor:innen

artificial intelligencecomplete blood countimmune thrombocytopeniapredictionresponse

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • Department of Hematology, Cangzhou Central Hospital, Hebei, China.
  • Yidu Cloud Technology Inc, Beijing, China.
  • Centre for Haematology, Department of Immunology and Inflammation, Imperial College of Science, Technology and Medicine, London, UK.

Förderung

  • National Natural Science Foundation of China
  • Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences

Zitieren

APA

Zhai, X., Qi, S., Wang, X., Zhang, W., Chen, M., Shen, Q., Gong, X., Zhai, W., Liu, S., Liang, X., Ma, Y., Song, Z., Gale, R. P., Wang, J., Yang, R., Liu, X., Zhang, L., & Chen, J. (2026). Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106916

Vancouver

Zhai X, Qi S, Wang X, Zhang W, Chen M, Shen Q, et al. Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia. Research and Practice in Thrombosis and Haemostasis. 2026. doi:10.1016/j.rpth.2026.106916

BibTeX
@article{Zhai2026,
  author = {Zhai, Xiaolin and Qi, Saibing and Wang, Xiyan and Zhang, Wei and Chen, Mengyun and Shen, Qiujin and Gong, Xiaowen and Zhai, Wangsong and Liu, Sichang and Liang, Xuan and Ma, Yueshen and Song, Zhen and Gale, Robert Peter and Wang, Juan and Yang, Renchi and Liu, Xiaofan and Zhang, Lei and Chen, Junren},
  title = {Artificial intelligence prediction of therapy response in newly diagnosed adult severe primary immune thrombocytopenia},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.rpth.2026.106916}
}
Kostenlos starten →